跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IDACIO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IDACIO
Authorized
STANDARD
IDACIO
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7d7834113d6e8a0d
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
7d7834113d6e8a0d
Drug Approval Canada Name
IDACIO
Product Name
IDACIO
Status
Marketed
Status Date
2021-08-30
Original Market Date
2021-08-30
Din
02502682
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
90:24.16.92
Atc Original
L04AB04 ADALIMUMAB
Atc Name
l 04 ab 04
Aig Number
0150364003
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ADALIMUMAB
40 MG / 0.8 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7d7834113d6e8a0d
Type
Standard
Back to Health Canada Approvals